Literature DB >> 560909

RNA metabolism of murine leukemia virus: size analysis of nuclear pulse-labeled virus-specific RNA.

H Fan.   

Abstract

A system for excess DNA hybridization of Moloney murine leukemia virus (M-MuLV)-specific RNA from infected mouse cells with M-MuLV cDNA immobilized on nitrocellulose filters was developed. In the presence of unlabeled heterologous rabbit liver RNA, 0.3-0.5% of labeled, infected cell nuclear RNA bound to the filters, while 0.05% or less of nuclear RNA from uninfected cells bound. Sedimentation analysis of pulse-labeled nuclear RNA was performed, and hybridization across sucrose gradients indicated that the major pulse-labeled, virus-specific RNA was 38S, similar or identical in sedimentation to the virion subunit RNA. A minor component of pulse-labeled, virus-specific RNA larger than 38S, was detected (40-60S), but kinetic experiments indicated that it was not an obligate precursor to 38S virus-specific RNA. Simultaneous analysis of steady state and pulse-labeled, virus-specific nuclear RNA across sucrose gradients indicated that the 38S virus-specific RNA was not detectably different from the steady state "35S" nuclear RNA previously identified. More detailed resolution on agarose gels also showed no difference. Thus the primary transcript of M-MuLV-specific RNA appears to be 38S, the same size as stable cellular virus-specific RNA, and no evidence for a higher molecular weight precursor was found.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 560909     DOI: 10.1016/0092-8674(77)90046-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  11 in total

1.  Analysis of cytoplasmic RNA and polyribosmomes from feline leukemia virus-infected cells.

Authors:  A J Conely; L F Velicer
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

2.  Immunoglobulin light chain mRNA is processed from large nuclear RNA.

Authors:  M Gilmore-Hebert; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

3.  Characterization of intracellular viral RNA in interferon-treated cells chronically infected with murine leukemia virus.

Authors:  S Salzberg; M Bakhanashvili; S Bari; I Berman; M Aboud
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

4.  Size analysis and relationship of murine leukemia virus-specific mRNA's: evidence for transposition of sequences during synthesis and processing of subgenomic mRNA.

Authors:  H Fan; I M Verma
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

5.  Methylation state and DNase I sensitivity of chromatin containing Moloney murine leukemia virus DNA in exogenously infected mouse cells.

Authors:  P E Montandon; F Montandon; H Fan
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

6.  Structure of Moloney murine leukemia viral DNA: nucleotide sequence of the 5' long terminal repeat and adjacent cellular sequences.

Authors:  C Van Beveren; J G Goddard; A Berns; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

7.  Virus-specific RNA synthesis in interferon-treated mouse cells productively infected with Moloney murine leukemia virus.

Authors:  H Fan; P MacIsaac
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

8.  High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range.

Authors:  R D Cone; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

9.  Genome organization of retroviruses. V. In vitro-synthesized Moloney murine leukemia viral DNA has long terminal redundancy.

Authors:  R A Bosselman; I M Verma
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

10.  Induction of endogenous guinea pig retrovirus by 5-bromodeoxyuridine: amplification of virus-specific RNA.

Authors:  A R Davis; D P Nayak; J Lofgren
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.